Table 2. Tumour characteristics of the MBC patients.
| Characteristic | No. of patients (%) | |
|---|---|---|
| Tumor size – Mean (range) | 5.8 (2–10) cm | |
| Nipple involvement | 61 (57.5%) | |
| Histology | IDC Undifferentiated Papillary |
96 (90.5%) 06 (5.7%) 04 (3.8%) |
| Tumor | T2 | 28 (26.4%) |
| T3 | 55 (51.9%) | |
| T4a | 08 (07.5%) | |
| T4b | 15 (14.2%) | |
| Node | N2a | 42 (62.7%) |
| N3b | 17 (25.3%) | |
| N3c | 08 (12%) | |
| Stage | II | 39 (36.8%) |
| IIa | 26 (24.5%) | |
| IIb | 13 (12.3%) | |
| III | 46 (43.4%) | |
| IIIa | 32 (30.2%) | |
| IIIb | 02 (1.9%) | |
| IIIc | 12 (11.3%) | |
| IV | 21 (19.8%) | |
| ER | 44 (41.5%) | |
| PR | 27 (25.5%) | |
| Her-2-neu | Positive | 09 (8.5%) |
| Negative | 46 (43.4%) | |
| Unknown | 51 (48.1%) | |
| TNBC | 22 (20.8%) | |
| Early disease | 39 (36.8%) | |
| Locally advanced disease | 46 (43.6%) | |
| Metastatic disease | 21 (19.8%) |